GlycosBio Inc.
1 additional officer or director, 5 additional investors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 2 investorsnamed
2 investors on record.
The investors already on the cap table shape who leads the next round.
- 4 directorsboard
4 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 5
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 2
Financing history
- Mar 6, 2024Form D equity offering · $1.1M (form d sold) · 5 investorsFact Form D · “GlycosBio Inc. filed Form D: $1,125,000 sold of $5,000,000, Biotechnology”
- Feb 15, 2013Form D equity offering · $3.0M (form d sold)Mercury Fund via Daniel Marvin WatkinsFact Form D · “Glycos Biotechnologies Inc Form D, first filed 2013-02-28”
- Oct 8, 2010Form D equity offering · $4.2M (form d sold)Mercury Fund via Daniel Marvin WatkinsFact Form D · “Glycos Biotechnologies Inc Form D, first filed 2010-10-20”
- Oct 8, 2010Form D equity offering · $4.2M (form d sold)Fact Form D
- Mar 24, 2009Form D equity offering · $2.4M (form d sold)Fact Form D
Who would invest
How comparable investors are foundComparable investors backed two or more of the companies this company’s own investors also back. Broader fit co-invested two or more times with them and dated a new company in the last 12 months. Each reason is a fact on record: a shared company, a co-investment count, a dated deal, a stage or round size it has joined. A shared sector alone never puts a firm here. Nothing is a prediction that a firm will invest.Already invested
2 investors on record- Mercury Fund form d related, Daniel Marvin Watkins (strongly supported) Inference sec.gov
- Mercury Fund form d related, Daniel Marvin Watkins (strongly supported) Inference sec.gov
- Mercury Fund form d related, Daniel Marvin Watkins (strongly supported) Inference sec.gov
Strong comparable investors
0 firmsFirms that backed two or more of the companies this company's own investors also back.
No firm backed two or more of the companies this company's investors back, so there is no comparable investor on record yet.
Broader fit
0 firmsFirms that co-invest repeatedly with this company's investors and dated a new company in the last 12 months.
No other firm co-invests repeatedly with this company's investors on record.
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
- Richard C. Cilento Executive Officer/Director sec.gov
- Victoria C. Jr. Niklas Director Fact
- John C. Jr. Replogle Director Fact
- Frank C. Jr. Foster Director Fact
Timeline
- Mar 21, 2024GlycosBio Inc. filed Form D: $1,125,000 sold of $5,000,000, BiotechnologyForm D filed Fact Form D
Evidence
Every observation on this company
- Entity type: Corporation Mar 21, 2024 Fact Form D
- Form D industry group: Biotechnology Mar 21, 2024 Fact Form D
- Amendment: false Mar 21, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Mar 21, 2024 Fact Form D
- Incorporated: overFiveYears Mar 21, 2024 Fact Form D
- Jurisdiction: Delaware Mar 21, 2024 Fact Form D
- Amount sold (Form D): $1.1M Mar 21, 2024 Fact Form D
- Offering amount (Form D): $5.0M Mar 21, 2024 Fact Form D
- Exemptions: 06b Mar 21, 2024 Fact Form D
- First sale: 2024-03-06 Mar 21, 2024 Fact Form D
- Investors (Form D): 5 Mar 21, 2024 Fact Form D
- Minimum investment (Form D): 25,000 Mar 21, 2024 Fact Form D
- Securities offered: equity Mar 21, 2024 Fact Form D
- Office address: Mar 21, 2024 Fact Form D
Record history
- Form D filed2024-03-21source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.